School of Materials Science and Engineering, and Tianjin Key Laboratory of Composite and Functional Materials, Tianjin University, Tianjin, China.
J Mater Sci Mater Med. 2012 Feb;23(2):419-29. doi: 10.1007/s10856-011-4493-2. Epub 2011 Nov 18.
Porous scaffolds that can prolong the release of bioactive factors are urgently required in bone tissue engineering. In this study, PLGA/gelatin composite microspheres (PGMs) were carefully designed and prepared by entrapping poly(L: -lactide-co-glycolide) (PLGA) microspheres (PMs) in gelatin matrix. By mixing PGMs with PLGA solution directly, drug-loaded PLGA/carbonated hydroxyapatite (HAp)/PGMs composite scaffolds were successfully fabricated. In vitro release of fluorescein isothiocyanate-dextran (FD70S) as a model drug from the scaffolds as well as PMs and PGMs was studied by immersing samples in phosphate buffered saline (pH = 7.4) at 37°C for 32 days. Compared with PMs, PGMs and PLGA/HAp/PGMs scaffolds exhibited slow and steady release behavior with constant release rate and insignificantly original burst release. The swelling of PGMs, diffusion of drugs, and degradation of polymer dominated the release behaviors synergistically. The PLGA/HAp/PGMs scaffold offers a novel option for sequential or simultaneous release of several drugs in terms of bone regeneration.
在骨组织工程中,迫切需要能够延长生物活性因子释放的多孔支架。在这项研究中,通过将聚(L:-丙交酯-co-乙交酯)(PLGA)微球(PMs)包埋在明胶基质中,精心设计并制备了 PLGA/明胶复合微球(PGMs)。通过将 PGMs 与 PLGA 溶液直接混合,成功制备了载药 PLGA/碳酸羟基磷灰石(HAp)/PGMs 复合支架。通过将样品在 37°C 的磷酸盐缓冲盐水(pH = 7.4)中浸泡 32 天,研究了荧光素异硫氰酸酯-葡聚糖(FD70S)作为模型药物从支架以及 PMs 和 PGMs 中的体外释放情况。与 PMs 相比,PGMs 和 PLGA/HAp/PGMs 支架表现出缓慢而稳定的释放行为,具有恒定的释放率和微不足道的原始突释。PGMs 的溶胀、药物的扩散和聚合物的降解协同主导了释放行为。PLGA/HAp/PGMs 支架为几种药物的顺序或同时释放提供了一种新的选择,以促进骨再生。